19. [IF=4.8] Congcong Zhang et al."Mechanistic Evaluation of Roxadustat for Pulmonary Fibrosis: Integrating Network Pharmacology, Transcriptomics, and Experimental Validation."Pharmaceuticals.2026 Jan;19(1):179 18. [IF=12.5] Binghua Wang et al."A softness zwitterionic micelles efficiently deliver inhaled nintedanib by enhancing airway mucus penetration."Science Advances.2026 Jan;12(1) 17. [IF=15.7] Li Chuyu et al."A nanosystem targeting tissue inhibitor of metalloproteinase-1 for continuous spatiotemporal idiopathic pulmonary fibrosis therapy."Nature Communications.2026 Jan;: 16. [IF=4.2] He Xin et al."Deubiquitinase USP53 suppressed tumorigenesis of colorectal cancer cells by mediating deubiquitination of MORF4L1."BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE.2025 Oct;:168067 15. [IF=13.2] Qian Luo et al."Recombinant PD1 liposome loading nintedanib for pulmonary fibrosis therapy in mice."CHEMICAL ENGINEERING JOURNAL.2025 Dec;525:169905 14. [IF=12] Ziyi Chen et al."TAT-PBX1 fusion protein alleviates LPS-induced acute lung injury via AMPK-TFAM signaling activation."MOLECULAR THERAPY. 13. [IF=4.8] Song Cheng et al."Pulmonary delivery of excipient-free tobramycin DPIs for the treatment of Pseudomonas aeruginosa lung infection with CF."Frontiers in Pharmacology.2025 Jun;16: 12. [IF=8.2] Lei Wang et al."Phospholipase A2 Group IIA activates Indoleamine 2,3-dioxygenase 1 to drive the progression of pulmonary fibrosis."FREE RADICAL BIOLOGY AND MEDICINE.2025 Jun;: 11. [IF=9.6] Yue Zhang et al."Engineered MSC Aggregates with E/N-Cadherin and IL-6 Preconditioning for the Treatment of Systemic Sclerosis."Advanced Healthcare Materials.2025 Jun;:2500663 10. [IF=13.6] Liran Xu et al."PIEZO1 mediates periostin+ myofibroblast activation and pulmonary fibrosis in mice."JOURNAL OF CLINICAL INVESTIGATION.2025 Jun;135(11): 9. [IF=14.7] Lei Wang et al."The crucial function of IDO1 in pulmonary fibrosis: From the perspective of mitochondrial fusion in lung fibroblasts and targeted molecular inhibition."Acta Pharmaceutica Sinica B.2025 Apr;: 8. [IF=11.7] Yan Wang et al."Realveolarization with inhalable mucus-penetrating lipid nanoparticles for the treatment of pulmonary fibrosis in mice."Science Advances.2024 Jun;10(24) 7. [IF=9.2] Jianzhi Wu et al."SGK1 aggravates idiopathic pulmonary fibrosis by triggering H3k27ac-mediated macrophage reprogramming and disturbing immune homeostasis."International Journal of Biological Sciences.2024; 20(3): 968–986 6. [IF=10.2] Zheng Meiling et al."Traditional Chinese medicine inspired dual-drugs loaded inhalable nano-therapeutics alleviated idiopathic pulmonary fibrosis by targeting early inflammation and late fibrosis."JOURNAL OF NANOBIOTECHNOLOGY.2024 Dec;22(1):1-19 5. [IF=7.9] Yanliang Wu et al."Specneuzhenide improves bleomycin-induced pulmonary fibrosis in mice via AMPK-dependent reduction of PD-L1."PHYTOMEDICINE.2023 Dec;:155318 4. [IF=5.735] Guo-qing Ren et al."Ginseng saponin metabolite 20(S)-protopanaxadiol relieves pulmonary fibrosis by multiple-targets signaling pathways."Journal of Ginseng Research.2023 Jan;: 3. [IF=5.195] San Fu et al."Synergistic effect of constituent drugs of Baibutang on improving Yin-deficiency pulmonary fibrosis in rats."JOURNAL OF ETHNOPHARMACOLOGY.2022 Dec;:116050 2. [IF=0] Kexin Jia et al."A novel pulmonary fibrosis murine model with immune-related liver injury."Animal Models and Experimental Medicine.2022 Aug;: 1. [IF=6.388] Yue Ding et al."Bryodulcosigenin attenuates bleomycin-induced pulmonary fibrosis via inhibiting AMPK-mediated mesenchymal epithelial transition and oxidative stress."PHYTOTHERAPY RESEARCH